hotspot -WSS

hotspot

author：fashion 2025-09-06 03:50:37 - browse：45

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

knowledge

WSS

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Study on Amgen’s bispecific immunotherapy produces positive data

Study on Amgen’s bispecific immunotherapy produces positive data

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Tome Biosciences co

ACIP vaccine advisory panel sees its vacancies filled

knowledge

hotspot

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Affirmative action in medical school literally saved lives

STAT Summit: Meghan O’Rourke on making chronic illness visible

Sports medicine is finally prioritizing gender equality

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Peter Hotez and the public health issue of online harassment

Abbott's new heart device gets FDA advisory panel nod

Guidelines to prevent youth baseball injuries need more muscle

Study gives hint on South Asians’ higher risk of cardiovascular disease

hotspot

Readout LOUD podcast: Live from the 2023 STAT Summit

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

ACIP vaccine advisory panel sees its vacancies filled

Tome Biosciences co

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Report cites 'urgent' need to recruit more diverse clinical trial participants

focus

explore

knowledge

focus